DME Capital Management Amends Green Brick Partners Filing
Ticker: GRBK-PA · Form: SC 13D/A · Filed: Nov 15, 2024 · CIK: 1373670
Sentiment: neutral
Topics: sec-filing, schedule-13d, amendment
Related Tickers: GRBK
TL;DR
DME Capital Management filed an update on their Green Brick Partners stake. Details TBD.
AI Summary
DME Capital Management, LP, along with David Einhorn and DME Advisors GP, L.L.C., filed an amendment (No. 27) to their Schedule 13D on November 15, 2024, regarding their holdings in Green Brick Partners, Inc. The filing indicates a change in their reporting, but the specific details of the change in beneficial ownership or the exact number of shares held are not provided in this excerpt.
Why It Matters
This amendment signals a potential shift in the investment strategy or reporting of a significant holder in Green Brick Partners, which could influence market perception and stock price.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate changes in significant shareholder positions, which can lead to increased volatility.
Key Players & Entities
- DME Capital Management, LP (company) — Filing entity
- David Einhorn (person) — Group member
- DME Advisors GP, L.L.C (company) — Group member
- Green Brick Partners, Inc. (company) — Subject company
FAQ
What is the specific change in beneficial ownership reported in this amendment?
The provided excerpt does not specify the exact change in beneficial ownership or the number of shares held.
What is the CUSIP number for Green Brick Partners, Inc. common stock?
The CUSIP number for Green Brick Partners, Inc. common stock is 392709101.
When was Amendment No. 27 to Schedule 13D filed?
Amendment No. 27 to Schedule 13D was filed on November 15, 2024.
Who are the named group members filing this amendment?
The named group members are David Einhorn, DME Advisors GP, L.L.C, and DME Advisors, L.P.
What is the primary business of Green Brick Partners, Inc. according to the filing?
Green Brick Partners, Inc. is in the Operative Builders industry, SIC code 1531.
Filing Stats: 1,927 words · 8 min read · ~6 pages · Grade level 10.2 · Accepted 2024-11-15 16:01:38
Key Financial Figures
- $0.01 — uer) Shares of Common Stock, par value $0.01 per share (Title of Class of Securitie
- $69.16 — ommon Stock to the Issuer at a price of $69.16 per share, and GCOM and the SMA purchas
Filing Documents
- 13da.htm (SC 13D/A) — 74KB
- 0000929638-24-003941.txt ( ) — 76KB
Purpose of Transaction
Item 4. Purpose of Transaction On November 13, 2024, in connection with a reallocation of shares of Common Stock among GCOM, the SPVs, the SMA and SILP, the SPVs and SILP sold an aggregate of 1,017,163 shares of Common Stock to the Issuer at a price of $69.16 per share, and GCOM and the SMA purchased the same number of shares of Common Stock from the Issuer at the same price. The sale of shares of Common Stock to the Issuer and purchase of shares of Common Stock from the Issuer were approved by the Board of Directors of the Issuer in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Such transactions did not result in any change in the number of shares of Common Stock beneficially owned by the Reporting Persons.
Interest in Securities of the Issuer
Item 5. Interest in Securities of the Issuer. (a) and (b) See Items 7-13 of the cover pages. The percentages reported herein are based on a statement in the Quarterly Report on Form 10-Q filed by the Issuer with the SEC on October 30, 2024 that there were 44,498,248 shares of Common Stock outstanding as of October 25, 2024. (c) The information described in Item 4 is hereby incorporated by reference into this Item 5(c). The Reporting Persons have not engaged in any other transactions in the Common Shares during the sixty day period prior to the filing of this Schedule 13D that have not previously been reported.
Exhibits
Item 7. Exhibits. Exhibit 99.1 Joint Filing Agreement executed by and among the Reporting Persons as of March 28, 2014 (incorporated herein by reference to Exhibit 99.2 to Amendment No. 8 to Schedule 13D relating to shares of Common Stock of the Issuer, as filed by the Reporting Persons with the Commission on March 28, 2014) SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 15, 2024 DME Advisors GP, L.L.C. By: /s/ Daniel Roitman Daniel Roitman Chief Operating Officer DME Advisors, L.P. By: /s/ Daniel Roitman Daniel Roitman Chief Operating Officer DME Capital Management, LP By: /s/ Daniel Roitman Daniel Roitman Chief Operating Officer /s/ Daniel Roitman** Daniel Roitman, on behalf of David Einhorn ** The Power of Attorney executed by David Einhorn, authorizing the signatory to sign and file this report on David Einhorn's behalf, filed as Exhibit 99.1 to the Schedule 13D filed with the Securities and Exchange Commission on August 29, 2019 by the Reporting Persons with respect to the common units of CONSOL Coal Resources, is hereby incorporated by reference.